Source: Markets Insider

Midas Pharma: DGAP-News: APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan-European intellectual property rights

DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance/Market launch APONTIS PHARMA and Midas Pharma agree on further development partn...

Read full article »
Midas Pharma's Competitors | Midas Pharma's News | Midas Pharma's Financials
Stay up-to-date with the latest news on Midas Pharma
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Karl-Heinz Schleicher's photo - President & CEO of Midas Pharma

President & CEO

Karl-Heinz Schleicher

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Midas Pharma